CoChat

Modeling Human Nonalcoholic Fatty Liver Disease (NAFLD) with an Organoids-on-a-Chip System

Wang, Yaqing, Wang, Hui, Deng, Pengwei, Tao, Tingting, Liu, Haitao, Wu, Shuo, Chen, Wenwen, Qin, Jianhua · 2020 · ACS Biomaterials Science & Engineering

The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a common metabolic and progressive disease, which has emerged as a major cause of chronic liver disease worldwide. It is characterized by the process ranging from simple steatosis to nonalcoholic steatohepatitis. However, a deep understanding of NAFLD progression remains challenging due to the lack of proper in vitro human disease models. In this work, we proposed a new strategy to establish a human NAFLD model based on a human-induced pluripotent stem cell (hiPSC)-derived liver organoids-on-a-chip system. This system allows us to characterize the pathological features of NAFLD in liver organoids by exposure to free fatty acids (FFAs) in perfused three-dimensional (3D) cultures during a prolonged period. Upon FFA induction, liver organoids exhibited lipid droplet formation and triglyceride accumulation. Moreover, they showed upregulated expressions of lipid metabolism-associated genes, indicating the abnormal lipid metabolic process in NAFLD. The FFA-exposed organoids also showed reactive oxygen species (ROS) production and elevated expression of various inflammatory cytokine genes and fibrogenic markers. These alterations represented the typical biochemical characteristics of NAFLD progression, which may provide insight into the potential mechanisms underlying steatosis. The proposed human NAFLD-on-a-chip model combines stem cell organoids with organs-on-chips, which may provide a promising platform for extending their applications for disease studies and effective therapies.

Overview

Integrity signals

Registry

Crossref · 10.1021/acsbiomaterials.0c00682

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Cui W., 2010, Am. J. Transl. Res., 2, 95

Cited by

See all 109

Metadata

Authors
Wang, Y., Wang, H., Deng, P., Tao, T., Liu, H., Wu, S., Chen, W., & Qin, J.
Affiliations
  • Dalian Institute of Chemical Physics (CN)
  • Dalian University of Technology (CN)
Corresponding author
Qin, Jianhua
Venue
ACS Biomaterials Science & Engineering
Published
2020-09-16
Volume
6
Issue
10
Pages
5734-5743
ISSN
2373-9878 (ISSN-L)
OpenAlex
W3087345910
Cited by
109
References
49
Citations by year
2026: 19 · 2025: 18 · 2024: 24 · 2023: 18 · 2022: 19 · 2021: 10 · 2020: 1
FWCI
8.59
Type
journal article
Language
en
Open access
closed
Locations
  • ACS Biomaterials Science & Engineering (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministry of Science and Technology of the People's Republic of China (2018ZX09201017-001-001)
  • Dalian Institute of Chemical Physics (DICP I201934)
  • National Natural Science Foundation of China (31671038, 81703470, 81803492)
  • Chinese Academy of Sciences (XDA16020900, XDB29050301, XDB32030200)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
non-alcoholic fatty liver disease, liver organoids, organ-on-a-chip, induced pluripotent stem cells, free fatty acids, lipid droplet formation, triglyceride accumulation, lipid metabolism, reactive oxygen species, inflammation, liver fibrosis, steatosis, disease modeling
MeSH terms
Humans, Organoids, Lipid Metabolism, Lab-On-A-Chip Devices, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.